GlassScriptPhysician profile
Lee Brandon Epstein
NPI 1174518401
$5,764.25
in general payments reported to CMS, 2019-2025
14 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Urology) provider received nationally (typical 2025 total: $782).
See the full distribution for Urogynecology and Reconstructive Pelvic Surgery (Urology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,085 · 2020: $54.74 · 2021: $13.84 · 2022: $286 · 2023: $45.14 · 2024: $168 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $324.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $4,968.72 | 2019-2022 | |
| Coloplast Corp | $335.18 | 2019-2025 | |
| Escala Medical INC. | $167.76 | 2024 | |
| Caldera Medical, INC | $64.47 | 2022 | |
| Axonics, INC. | $45.14 | 2023 | Bulkamid, Axonics |
| Pfizer INC. | $34.27 | 2019 | |
| Therapeuticsmd, INC. | $30.94 | 2019 | |
| Karl Storz Endoscopy-America | $26.43 | 2019 | |
| 180 Medical, INC. | $20.24 | 2019 | |
| Boston Scientific Corporation | $16.58 | 2019 | |
| Bard Access Systems, INC. | $16.24 | 2019 | |
| Mission Pharmacal Company | $13.84 | 2021 | |
| Medtronic USA, INC. | $12.28 | 2020 | |
| Allergan, INC. | $12.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Epstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.